Pressemitteilung: FedEx Passes Milestone in CEIV Pharma Certifications
FedEx now holds 30 IATA CEIV Pharma certifications August 28, 2026 – MEMPHIS, Tennessee – FedEx Corp. (NYSE: FDX) has achieved a major milestone in its healthcare logistics journey, securing 30 IATA CEIV Pharma certifications across its global air hubs and cargo handling facilities. This accomplishment positions FedEx among the top global transportation providers with one of the industry’s largest networks recognized for excellence in pharmaceutical handling. This underscores a commitment to precision and quality and is a testament to the capabilities leveraged by FedEx Life Sciences in transporting critical, temperature-sensitive shipments for the healthcare industry. “The pharmaceutical industry relies on air transport to ensure that time-sensitive and temperature-controlled medicines and therapies reach the doctors and patients who depend on them,” said Brendan Sullivan, global head of cargo at IATA. “We are pleased to see FedEx earn the industry’s trusted mark of quality and excellence in pharmaceutical handling while continuing to expand its global network.” (....)
Der vollständige Inhalt dieser Pressemitteilung wird auf unserer Seite nicht angezeigt. Zum Lesen der Mitteilung klicken Sie bitte auf den folgenden Link:
Stichwörter: Federal Express Corporation Inc. (FedEx), IATA CEIV Pharma (Center of Excellence for Independent Validators Pharma), healthcare logistics, global air hubs, cargo handling facilities, pharmaceutical handling, temperature‑sensitive shipments, FedEx Life Sciences, air transport medicines therapies, global network expansion, carbon‑neutral operations 2040, transportation providers